One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis

One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis

Abstract Background Diabetes mellitus (DM) and cardiovascular diseases often co-exist. Today, percutaneous coronary intervention (PCI) is the preferred revascularization procedure for majority of patients with coronary artery disease. Polymer-free amphilimus-eluting stents (AES) represent a novel el...

Full description

Bibliographic Details
Main Authors:	Hong Wang, Xiaoya Xie, Quannan Zu, Ming Lu, Rongfa Chen, Zhiren Yang, Yongqiang Gao
Format:	Article
Language:	English
Published:	BMC 2022-10-01
Series:	Cardiovascular Diabetology
Subjects:	Diabetes mellitus Polymer-free Amphilimus-eluting stents Durable polymer zotarolimus-eluting stents Percutaneous coronary intervention Cardiovascular outcomes Target lesion failure
Online Access:	https://doi.org/10.1186/s12933-022-01673-8

Similar Items

Comparison of 3-year clinical outcomes between Endeavor Resolute® and Resolute Integrity® zotarolimus-eluting stents in an Asian population
by: Yong Hoon Kim, et al.
Published: (2020-04-01)

Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Endrin Koni, et al.
Published: (2021-03-01)

Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis
by: Hong Wang, et al.
Published: (2023-08-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
by: Juan F. Iglesias, et al.
Published: (2019-11-01)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
by: Minsu Kim, et al.
Published: (2023-06-01)

Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease
by: Ameer E. Hassan, et al.
Published: (2020-09-01)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
by: Flavius-Alexandru Gherasie, et al.
Published: (2023-04-01)

Efficacy and safety of durable versus biodegradable polymer drug-eluting stents in patients with acute myocardial infarction complicated by cardiogenic shock
by: Woo Jin Jang, et al.
Published: (2024-03-01)

Clinical Outcomes of Biodegradable versus Durable Polymer Drug Eluting Stents in Rotational Atherectomy: Results from ROCK Registry
by: Kyung An Kim, et al.
Published: (2022-10-01)

Ultra-thin everolimus-eluting stents in atherosclerotic lesions: Three years follow-up with subgroup analysis of ultra-long stents
by: Raghava Sarma Polavarapu, et al.
Published: (2023-07-01)

Polymer Free Amphilimus Drug Eluting Stent for Infrapopliteal Arterial Disease in Patients with Critical Limb Ischemia: A New Device in the Armamentarium
by: Konstantinos Tigkiropoulos, et al.
Published: (2022-12-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
by: I. Rykowska, et al.
Published: (2020-10-01)

Triple-vessel coronary artery aneurysms following drug-eluting stents
by: Immaneni Sathyamurthy, et al.
Published: (2023-01-01)

Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
by: Eline H. Ploumen, et al.
Published: (2022-11-01)

Drug-eluting coronary stents in clinical practice: lessons from the «BAsel Stent Kosten-Effektivitäts Trials» (BASKET)
by: Swiss Medical Weekly
Published: (2011-08-01)

Drug-Eluting Stents: Technical and Clinical Progress
by: Maciej Koźlik, et al.
Published: (2023-02-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature
by: Prashanth Panduranga, et al.
Published: (2011-01-01)

Interim Results of the Basket of Real-World Randomised Clinical PRISM Trials for M’Sure-S, a Next-Generation Sirolimus-Eluting Stent, Versus Eliminator, an Everolimus-Eluting Stent
by: Marc Silvestri, et al.
Published: (2018-09-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01)

Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
by: M. V. Chernyayev, et al.
Published: (2019-04-01)

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence
by: Francesco Condello, et al.
Published: (2023-02-01)

Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents
by: Pierre Brami, et al.
Published: (2023-10-01)

Clinical analysis of permanent, biodegradable and polymer-free drug eluting stent in treatment of unprotected left main coronary artery disease
by: ZHOU Denglu, et al.
Published: (2019-03-01)

Frequency of In-Stent Restenosis among Different 2nd/3rd Drug Eluting Stents in Patients Presenting with ACS/Angina at Trtiary Cradiac Care Centre
by: Shakir Ghaffar, et al.
Published: (2022-11-01)

Influence of Polymer Composition on the Controlled Release of Docetaxel: A Comparison of Non-Degradable Polymer Films for Oesophageal Drug-Eluting Stents
by: Paris Fouladian, et al.
Published: (2020-05-01)

POR QUÉ USAR PREFERENTEMENTE STENTS NO FARMACOACTIVOS / Why it is preferable to use non-drug-eluting stents
by: Rosa Lázaro García, et al.
Published: (2013-10-01)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
by: Talha Ahmed, et al.
Published: (2022-10-01)

Natural history of coronary stents: 14 year follow-up of drug eluting stents versus bare metal stents
by: Rohit Sunil Walse, et al.
Published: (2023-11-01)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
by: Xiaohang Yuan, et al.
Published: (2023-08-01)

Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus-eluting stent in patients with coronary artery disease
by: Suresh Patted, et al.
Published: (2020-07-01)

Outcomes of supraflex sirolimus eluting coronary stents
by: Vishal Virendra Singh, et al.
Published: (2022-01-01)

Outcomes of supraflex Sirolimus-eluting coronary stents
by: Vishal Virendra Singh, et al.
Published: (2022-01-01)

Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis
by: Soonchan Park, et al.
Published: (2013-02-01)

Nine-Months Clinical Outcome of Biodegradable Polymer Coated Sirolimus-eluting Stent System: A Multi-Centre “Real-World” Experience
by: Raghava Sarma, et al.
Published: (2015-08-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
by: Mohammad Saifur Rohman, et al.
Published: (2023-07-01)

Safety and Efficacy of Post-Dilation in Percutaneous Coronary Intervention Using Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents
by: Yonghoon Shin, et al.
Published: (2023-09-01)

Clinical safety and effectiveness of the Genoss drug-eluting stent in real-world clinical practice
by: Young Jin Youn, et al.
Published: (2023-09-01)

Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry
by: Robert J. Gil, et al.
Published: (2020-02-01)